Federation des caisses Desjardins du Quebec’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-201,000	Closed	-$38.2K	–	2488
2023 Q2	$38.2K	Sell	201,000 -150,000	-43%	-$59.1K	﹤0.01%	1409
2023 Q1	$119K	Sell	351,000 -29,800	-8%	-$12.1K	﹤0.01%	1112
2022 Q4	$123K	Sell	380,800 -40,200	-10%	-$14.6K	﹤0.01%	1204
2022 Q3	$175K	Hold	421,000	–	–	﹤0.01%	1133
2022 Q2	$183K	Sell	421,000 -45,000	-10%	-$41.4K	﹤0.01%	1146
2022 Q1	$587K	Sell	466,000 -35,000	-7%	-$54K	0.01%	789
2021 Q4	$651K	Sell	501,000 -20,000	-4%	-$31.9K	0.01%	777
2021 Q3	$1.07M	Sell	521,000 -20,050	-4%	-$35.5K	0.01%	669
2021 Q2	$855K	Sell	541,050 -10,000	-2%	-$18.5K	0.01%	745
2021 Q1	$1.22M	Sell	551,050 -25,000	-4%	-$65.9K	0.01%	620
2020 Q4	$1.43M	Hold	576,050	–	–	0.02%	554
2020 Q3	$1.42M	Sell	576,050 -25,000	-4%	-$72.8K	0.02%	481
2020 Q2	$2.13M	Sell	601,050 -15,000	-2%	-$47.4K	0.03%	368
2020 Q1	$1.44M	Sell	616,050 -35,000	-5%	-$98.2K	0.03%	428
2019 Q4	$1.43M	Sell	651,050 -50,000	-7%	-$98.7K	0.02%	549
2019 Q3	$1.28M	Buy	701,050 +1,000	+0.1%	+$1.75K	0.02%	572
2019 Q2	$1.02M	Hold	700,050	–	–	0.01%	641
2019 Q1	$1.38M	Sell	700,050 -23,593	-3%	-$50K	0.02%	513
2018 Q4	$948K	Sell	723,643 -30,150	-4%	-$55.2K	0.02%	608
2018 Q3	$1.85M	Hold	753,793	–	–	0.03%	480
2018 Q2	$2.53M	Hold	753,793	–	–	0.04%	373
2018 Q1	$3.19M	Sell	753,793 -55,000	-7%	-$191K	0.05%	296
2017 Q4	$2.67M	Sell	808,793 -40,699	-5%	-$148K	0.04%	361
2017 Q3	$3.25M	Hold	849,492	–	–	0.05%	290
2017 Q2	$3.74M	Hold	849,492	–	–	0.06%	260
2017 Q1	$3.08M	Buy	+849,492	New	+$2.8M	0.06%	258

Other funds holding NYMX

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

ODIJL

One Day In July LLC Burlington, Vermont $1.44B AUM 17.18% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's NYMX Position: Q3 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 201,000 shares — an estimated $38.2K sold.

Federation des caisses Desjardins du Quebec first reported a position in NYMX in Q1 2017 and held it in 26 quarters. The position peaked at $3.74M in Q2 2017. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

Federation des caisses Desjardins du Quebec reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 201,000 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $38.2K.
Federation des caisses Desjardins du Quebec first reported a position in Nymox Pharmaceutical Corp in Q1 2017 and held it in 26 quarters.
Federation des caisses Desjardins du Quebec's Nymox Pharmaceutical Corp position peaked at $3.74M in Q2 2017.
5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2023, filed 15 Aug 2024.